Blog Posts (52)
March 16, 2016
STUDENT VOICES By: Kyle Pritz The scantiness of marijuana research in the United States of America shouldn’t come as a surprise to anyone. The lack of research is tremendous. However, with new decriminalizing laws budding up, the role of marijuana usage … Continue reading →
April 13, 2015
Note: The Bioethics Program blog is moving to its new home on April 1, 2015. Be sure to change your bookmarks to http://bioethics.uniongraduatecollege.edu/blog/ by Courtney Jarboe, Bioethics Program Student In Minnesota, residual dried blood (RDB) samples collected for newborn screening had been stored, retained, and used for research without parental consent. It had been presumed that the Minnesota Department of […]
March 31, 2015
Note: The Bioethics Program blog will be moving to its new home on April 1, 2015. Be sure to change your bookmarks to http://bioethics.uniongraduatecollege.edu/blog/ by Andrei Famenka, Bioethics Program Alum (2013) When it was first announced, I was particularly intrigued by a recent webinar called, ‘Gonorrhea, Guatemala and Gung-Ho Researchers: The Role of Controversy in Shaping Research Ethics Practice […]
March 27, 2015
Note: The Bioethics Program blog will be moving to its new home on April 1, 2015. Be sure to change your bookmarks to http://bioethics.uniongraduatecollege.edu/blog/ by Bonnie Steinbock, Bioethics Program Faculty An Italian scientist, Sergio Canavero, claims that he is two years away from performing the world’s first human head transplant, in which the head of one person would […]
September 9, 2014
by Karen Solomon, Bioethics Program Student Studies suggest that, before the advent of the Internet, we are unlikely to share minority or unpopular viewpoints with our co-workers, friends and relatives. This inclination creates, in essence, a “Spiral of Silence.” But does the Internet provide a remedy to the “Spiral of Silence,” by encouraging online discussion […]
August 20, 2014
by Karen Solomon, Bioethics Program Student Does early to bed and early to rise, make a man healthy, wealthy and more ethical? Earlier research suggested a “morning morality effect”: that people are more ethical early in the morning, becoming less so as they “wear out as a day wears on.” Not so fast, researchers now […]
August 14, 2014
by Sean Philpott-Jones, Director of the Center for Bioethics and Clinical Leadership There’s an epidemic that is sweeping this country. It’s not Ebola, despite all of the hype and misinformation about that disease that has dominated the news in the past two weeks. Rather, I’m talking about the ice bucket challenge. Anyone who has watched television […]
August 1, 2014
by Craig Klugman, Ph.D.
Is that shirt the cashier forget to ring up a bonus or do you point out the oversight?…
July 31, 2014
By Michelle N. Meyer, Assistant Professor and Director of Bioethics Policy I have a long article in Slate (with Union psychology professor Chris Chabris) on the importance of replicating science. We use a recent (and especially bitter) dispute over the failure to replicate a social psychology experiment as an occasion for discussing several things of much […]
May 22, 2014
by Sean Philpott-Jones, Director of the Center for Bioethics and Clinical Leadership We hosted a conference on Alzheimer’s disease at the College last week, inviting a distinguished group of physicians, researchers, caregivers, advocates and policymakers to discuss the ethical and legal challenges of diagnosing and treating those with the disease. These issues are particularly important to […]
View More Blog Entries
October 29, 2012 5:50 pm
New research raises doubts about the health benefits of the much-hyped red wine compound resveratrol. In a study from Washington University School of Medicine in St. Louis, healthy women in their late 50s and early 60s who took resveratrol supplements showed no improvement in factors linked to developing diabetes and heart disease. The finding suggests that resveratrol supplements do not benefit healthy people.
September 5, 2012 7:41 pm
Marc Hauser, a prolific scientist and popular psychology professor who last summer resigned from Harvard University, had fabricated data, manipulated results in multiple experiments, and described how studies were conducted in factually incorrect ways, according to the findings of a federal research oversight agency posted online Wednesday. The report provides the greatest insight yet into the problems that triggered a three-year internal university investigation that concluded in 2010 that Hauser, a star professor and public intellectual, had committed eight instances of scientific misconduct. The document, which will be published in the Federal Register Thursday, found six cases in which Hauser engaged in research misconduct in work supported by the National Institutes of Health. One paper was retracted and two were corrected, and other problems were found in unpublished work.
August 22, 2012 5:04 pm
A clinical trial being conducted by the Sutter Neuroscience Institute in Sacramento, California to address this situation began recruiting participants today for a highly experimental stem cell therapy for autism. The institute plans to find 30 autistic children between ages 2 and 7 with cord blood banked at the privately-run Cord Blood Registry, located about 100 miles west of the institute.
August 2, 2012 1:05 pm
Since the human genome was first sequenced in 2000, genome science has accelerated at a remarkable rate. Rapid advances in DNA-sequencing technology mean that affordable decoding of the human genome is not far away. In fact, human genomes could be sequenced for as little as $1,000 in the next few years. Unfortunately, the current biomedical research establishment is entirely unprepared for such a scenario.
July 29, 2012 9:31 am
Now his teams – working in tandem at the non-profit J. Craig Venter Institute and Synthetic Genomics, a biotech company in California – are well on the way to making synthetic microbes distinctly different to anything in nature. “We have a design contest to come up with a genome designed completely in a computer,” Venter says. “Three different versions of the genome are being constructed now and we hope to know by the end of the summer whether any of these designs will work as a living cell.”
July 18, 2012 10:11 am
A profile in Forbes by Matthew Herper, dubbed Venter “the Bono of genetics,” sniping that “he warps the reality field around genetic research through sheer force of ego and showmanship.” And yet Venter endures. Say what you will about his synthetic bacterium, no one else has achieved such a feat. And he is pressing on with other projects, more recently engineering a type of algae that is yellow rather than dark green, enabling light to pass through it so it can grow in greater density — providing what he hopes will be an ideal raw material for biofuel.
July 16, 2012 9:29 am
The rise of technology and research in the 21st century has brought about advances in biology and medicine, specifically in genetics. Anyone who has read the excellent cautionary tale Bloodline, by James Rollins, will wonder about the balance among morality, fate, and science, as well as how far science should go. American Thinker decided to go beyond Bloodline‘s fascinating adventure story to explore the narrative of genetics by interviewing some experts as well as the author, James Rollins.
July 13, 2012 1:16 pm
“In the research market our advantages are pretty limited,” says Reid. “We have higher quality. But in the research market that doesn’t matter very much. Researchers can work with lower quality data. That’s really been a startling revelation to us that despite the community saying quality is everything quality really isn’t everything.”
July 10, 2012 4:39 pm
In 2001, the Human Genome Project and Celera Genomics announced that after 10 years of work at a cost of some $400 million, they had completed a draft sequence of the human genome. Today, sequencing a human genome is something that a single researcher can do in a couple of weeks for less than $10,000.
June 22, 2012 11:46 am
One of the things I find very disturbing about the current approach to drugs, which is simply prohibition without necessarily any full understanding of harms, is that we lose sight of the fact that these drugs may well give us insights into areas of science that need to be explored and may give us new opportunities for treatment.
View More News Items